Severity of maternal infection and perinatal outcomes during periods of SARS-CoV-2 dominance in the UK Post date 2 March 2022 ← Use of tocilizumab and sarilumab alone or in combination with corticosteroids for covid-19 → Pregnancy and the “presumption of inclusion” in research